Chlorogenic Acid Oral Composition with 4-Vinylguaiacol for Balanced Sourness

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Chlorogenic acid-based compositions exhibit harshness and bitterness, limiting their continuous ingestion, while existing methods to enhance taste, such as incorporating β-damascenone and guaiacol, do not effectively address sourness in beverages with high chlorogenic acid and caffeine content.

Innovation Solution

An oral composition comprising 10-20% chlorogenic acid, 0.4-5% caffeine, and 4-vinylguaiacol in specific mass ratios, optionally with lactone, to impart and enhance sourness, balancing taste and reducing harshness.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chlorogenic acid reagent or low-roasting coffee bean is used as raw material to maximize chlorogenic acid content, then the physiological effect is enhanced, but the harshness and bitterness become too strong for continuous ingestion

Engineering Contradiction:
Improvephysiological effectVSAvoidharshness and bitterness
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces 4-vinylguaiacol as an intermediary substance that mediates between chlorogenic acid and the human palate. This compound specifically targets and suppresses the harshness and bitterness caused by chlorogenic acid, allowing high concentrations of the active ingredient to be ingested continuously without unpleasant taste effects

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the compositional parameters by incorporating 4-vinylguaiacol at a specific mass ratio (0.003 to 0.015 times the mass of chlorogenic acid). This parameter adjustment transforms the taste profile of the composition, reducing harshness while preserving the physiological benefits of high chlorogenic acid content

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If caffeine is added to high concentration chlorogenic acid to reduce sourness, then the sourness decreases, but the composition loses satisfactory sourness balance

Engineering Contradiction:
ImprovesournessVSAvoidtaste balance
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

4-vinylguaiacol acts as a mediator that selectively suppresses harshness and bitterness without affecting sourness. This allows the composition to maintain satisfactory sourness balance while eliminating the unpleasant harsh taste, achieving a more balanced taste profile than caffeine alone could provide

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the potentially harmful harshness and bitterness into a benefit by using 4-vinylguaiacol to selectively suppress these negative taste sensations. This allows the high chlorogenic acid content to be tolerated and continuously ingested, transforming what would be a harmful taste effect into an acceptable product characteristic

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Ease of operation

If existing taste improvement methods (β-damascenone and guaiacol) are used, then some taste aspects are improved, but sourness in high chlorogenic acid and caffeine beverages is not effectively addressed

Engineering Contradiction:
Improvetaste qualityVSAvoidsourness control
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameter by selecting 4-vinylguaiacol specifically, which has different taste-modifying properties compared to guaiacol and β-damascenone. This compound specifically targets harshness and bitterness suppression while preserving sourness, making it adaptable to high chlorogenic acid and caffeine beverages where existing methods fail

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP4599693A1Oral composition
Publication Date: 2025.08.13 KAO CORP
  • EP4599693A1 patent drawing
  • EP4599693A1 patent drawing
  • EP4599693A1 patent drawing

AI summary

Provided is an oral composition, including the following components (A), (B), and (C): (A) 10 mass% to 20 mass% of a chlorogenic acid; (B) 0.4 mass% to 5 mass% of caffeine; and (C) 4-vinylguaiacol, wherein a mass ratio of the component (C) to the component (B), [(C)/(B)], is 0.3×10-4 or more and 30×10-4 or less.